KROS earnings: a positive outcome, +9.7%

On March 25, 2021, Keros Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.7% in the window around the event. It had already run -9.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.